News: Press Release

TissueTech Inc. Awarded Four Patents for Proprietary Technology to Use Placental Tissue for Regenerative Medicine

Company has more than 40 issued patents MIAMI – September 14, 2017 – TissueTech Inc. announced today that it has been awarded four patents by the U.S. Patent Trademark Office. Two of the patents cover methods of promoting bone formation… read more

TissueTech, Inc. Names John Arnott, Industry Executive, to Board of Directors

Arnott brings experience in a wide range of global healthcare businesses MIAMI – August 3, 2017 – TissueTech Inc. announced today that it has named John Arnott to its Board of Directors. Mr. Arnott was most recently Operating Partner and… read more

TissueTech, Inc. Names Dr. Herbert B. Slade as Chief Medical Officer

MIAMI – August 1, 2017 – TissueTech, Inc. announced today that Herbert B. Slade, MD, has been named the company’s Chief Medical Officer (CMO). Dr. Slade, who will lead the execution of TissueTech’s clinical research strategies and be the primary… read more

Study Demonstrating Improved Outcomes in Pain Reduction and Function for Discectomy Patients with CLARIX® 100 Highlighted in Medical Journal

Proprietary technology demonstrates significant improvement in short-term and long-term outcomes. ATLANTA – July 10, 2017 – AMNIOX Medical, Inc., a TissueTechTM, Inc. company, announced today that the results of a clinical study on the efficacy of CLARIX Cryopreserved Amniotic Membrane in… read more

Amniox Medical Enters into Agreement with Intalere

ATLANTA, GA – June 8, 2017 – AMNIOX Medical, Inc., a TissueTech, Inc. company has announced an agreement with Intalere, to serve their members with its market leading human tissue allograft technology composed of both umbilical cord and amniotic membrane… read more

New Clinical Evidence Continues to Support the Effectiveness and Value of AMNIOX Medical Product

Nine Posters Demonstrating the Clinical Benefits of NEOX ® Wound Allograft Presented at SAWC ATLANTA, GA – May 8, 2017 – AMNIOX Medical, Inc., a TissueTech, Inc. company, announced today that nine clinical posters demonstrating the effectiveness of NEOX® Wound… read more

Bio-Tissue Announces Global Online Purchase Availability for Cliradex Light & Website Relaunch

  Bio-Tissue, a business unit  of TissueTech, Inc., today announced the global online availability of its newest product Cliradex Light advanced foaming eyelid cleanser on its newly redesigned website, www.cliradex.com. International purchases may be directed to Amazon Marketplace. Cliradex Light… read more

Bio-Tissue® Research Further Demonstrates Effectiveness of Cryopreserved Amniotic Membrane for Ocular Surface Healing

  LOS ANGELES, May 2, 2017 – Bio-Tissue, Inc., a business unit of TissueTech™, Inc., announces the presentation of key research at this week’s American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, May 5-9, further demonstrating the clinical… read more

AMNIOX Obtains Federal Supply Schedule Contract for NEOX® and CLARIX® Product Lines

Expanded Access to Industry-Leading Technology for 10.2 Million Military Personnel ATLANTA, GA – April 17, 2017 — AMNIOX Medical, Inc., a TissueTech, Inc. company, announced a new Federal Supply Schedule contract for its NEOX and CLARIX product lines. The agreement… read more

AMNIOX Highlights Three Studies Demonstrating Effectiveness of Umbilical Cord Tissue for Treating Chronic Wounds

Studies Document Healing Rates of 78% – 87% ATLANTA, GA – April 7, 2017 — AMNIOX Medical, Inc., a TissueTech, Inc. company, highlighted the publication of three studies concerning NEOX CORD 1K, its cryopreserved human umbilical cord tissue. In contrast… read more